Therapeutic attack of hypoxic cells of solid tumors: presidential address.


Hypoxic cells of solid tumors are relatively resistant to therapeutic assault. Studies have demonstrated that oxygen-deficient tumor cells exist in an environment conducive to reductive reactions making hypoxic cells particularly sensitive to bioreductive alkylating agents. Mitomycin C, the prototype bioreductive alkylating agent available for clinical use… (More)

3 Figures and Tables


  • Presentations referencing similar topics